Financial Summary (All financials)
| In millions, except per share items | Dec-25-21 | Dec-26-20 | Dec-28-19 | Dec-29-18 |
| Revenues | 1,920 | 1,558 | 1,303 | 2,409 |
| Revenue growth | 23.2% | 19.6% | -45.9% | |
| Cost of goods sold | 470 | 444 | 389 | 840 |
| Gross profit | 1,450 | 1,114 | 914 | 1,569 |
| Gross margin | 75.5% | 71.5% | 70.1% | 65.1% |
| Sales and marketing | 375 | 345 | 297 | 815 |
| Research and development | | | | 406 |
| General and administrative | | | | 253 |
| EBITA | 719 | 457 | 377 | 347 |
| EBITA margin | 37.4% | 29.3% | 28.9% | 14.4% |
| Amortization of intangibles | 170 | 251 | 253 | 484 |
| EBIT | 549 | 206 | 124 | -137 |
| EBIT margin | 28.6% | 13.2% | 9.5% | -5.7% |
| Pre-tax income | 87 | -205 | -151 | -450 |
| Income taxes | -160 | 5 | 38 | 62 |
| Earnings from continuing ops | 23 | -55 | -47 | -512 |
| Earnings from discontinued ops | 2,441 | -79 | -47 | |
| Net income | 849 | -118 | -47 | -512 |
| Net margin | 44.2% | -7.6% | -3.6% | -21.3% |
| |
| Diluted EPS | $0.14 | ($0.34) | | |
| Shares outstanding (diluted) | 170 | 162 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|